Table 1 Clinical and demographic features of Meniere Disease patients.
MDH (N = 8) | MDL (N = 34) | p | |
|---|---|---|---|
Sex (% woman) (N) | 50% (4) | 59% (20) | 0.7061 |
Age (mean ± SD) | 58.5 ± 6.6 | 58.0 ± 14.2 | 0.8832 |
Age of onset (mean ± SD) | 44.5 ± 13.2 | 45.02 ± 13.2 | 0.9208 |
Years of evolution (mean ± SD) | 14.0 ± 10.3 | 12.9 ± 7.8 | 0.7852 |
Laterality (% unilateral) (N) | 75% (6) | 74% (25) | 1.0000 |
Affected ear (% right) (N) | 25 (2) | 29 (10) | 0.8822 |
Family history of ear affections (% yes) (N) | 38% (3) | 59% (20) | 0.4330 |
Family history of MD (% yes) (N) | 25% (2) | 15% (5) | 0.6012 |
Headache (% yes) (N) | 38% (3) | 50% (17) | 0.6997 |
Migraine (% yes) (N) | 38% (3) | 29% (10) | 0.6861 |
History of Autoimmune disease (% yes) (N) | 38% (3) | 29% (10) | 0.6861 |
Number of crises in last 6 months (mean ± SD) | 2.0 ± 3.3 | 1.8 ± 2.7 | 0.8554 |
Hearing stage (%) (N) | 0.2398 | ||
1 | 20% (1) | 17% (5) | |
2 | 40% (2) | 31% (9) | |
3 | 0% (0) | 38% (11) | |
4 | 40% (2) | 14% (4) | |
AAO-HNS Functional Scale (%) (N) | 0.0968 | ||
1 | 67% (2) | 30% (9) | |
2 | 0% (0) | 22% (6) | |
3 | 0% (0) | 22% (6) | |
4 | 0% (0) | 19% (5) | |
5 | 0% (0) | 7% (2) | |
6 | 33% (1) | 0% (0) | |
Tumarkin crisis (% yes) (N) | 25% (2) | 12% (4) | 0.0562 |
Clinical MD group (%) (N) | 0.6635 | ||
Metachronic/ Classic (type 1) | 43% (3) | 39% (13) | |
Synchronic/ Delayed (type 2) | 0% (0) | 0% (0) | |
Familiar History (type 3) | 0% (0) | 15% (5) | |
Migraine (type 4) | 14% (1) | 21% (7) | |
Autoimmunity (type 5) | 43% (3) | 24% (8) |